International Clinical Trial: Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449325) titled 'Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: VahatiCor, Inc.

Condition: Angina Pectoris Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases Microvascular Angina

Intervention: Device: A-FLUX Reducer System

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 2026

Target Sample Size: 30

To know more, visit ...